肺伤后的呼吸机相关的腔体肺炎:一个病例报告
Alireza Rahat Dahmardeh1, Aliakbar Keykha2,3
1Department of Anesthesiology and Critical Care, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Journal of medical case reports
|November 19, 2025
概括
耐多药性大肠杆菌可导致呼吸器相关的腔内肺炎,这是一个罕见但新出现的疾病. 这一案例凸显了在诊断腔腔肺炎时需要考虑大肠杆菌的必要性,特别是在危急病患者中.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
背景情况:
- 呼吸器相关的洞腔性肺炎 (VCP) 通常是由常见的病原体引起的,如肺炎菌株,金黄色菌株,肺炎菌株,流感菌株和Pseudomonas aeruginosa.
- 与大肠杆菌相关的洞腔性肺炎是罕见的,主要发生在免疫受损的个体中.
- 越来越多的抗药性生物体的流行需要对VCP进行更广泛的差异诊断.
研究的目的:
- 报告一种罕见的VCP病例,由多药性耐药性大肠杆菌 (Escherichia coli) 引起.
- 为了强调大肠杆菌在VCP病因学中的新兴作用.
- 强调在VCP的差异诊断中考虑大肠杆菌的重要性.
主要方法:
- 病例报告详细介绍了一名27岁的伊朗巴鲁奇族裔男性患者.
- 患者在创伤后出现了肺伤和内出血.
- 确立了由多抗药性大肠杆菌引起的VCP的诊断.
主要成果:
- 患者患上了与呼吸机相关的洞腔性肺炎.
- 病原体被确定为多抗药性大肠杆菌.
- 这一案例凸显了大肠杆菌在重症患者中引起VCP的潜力.
结论:
- 大肠杆菌是呼吸机相关肺炎的新兴病原体.
- 在腔性肺炎的差异诊断中应考虑大肠杆菌,特别是在VCP的背景下.
- 这一案例扩大了对大肠杆菌作为VCP的原因的理解,超出了免疫受损人群.
相关概念视频
01:30Pneumonia I: Introduction
710
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
710
01:30Pneumonia III: Complications and Assessment
765
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
765
01:21Acute Respiratory Failure-II
992
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
992
01:27Pneumothorax-II
863
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
863
01:26Pneumothorax-I
1.1K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.1K
01:30Acute Respiratory Failure-III
740
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
740